Suzuki H - Search Results

1

A phase 2 trial of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer and without prior chemotherapy (JPN-201 study).

Matsubara N, Uemura H, Satoh T, Suzuki H, Nishiyama T, Uemura H, Hashine K, Imanaka K, Ozono S, Akaza H. Matsubara N, et al. Among authors: suzuki h. Jpn J Clin Oncol. 2014 Dec;44(12):1216-26. doi: 10.1093/jjco/hyu149. Epub 2014 Oct 15. Jpn J Clin Oncol. 2014. PMID: 25320340 Free PMC article. Clinical Trial.

2

Clinical characteristics of prostate cancer in elderly Japanese patients 80 years of age or older.

Suzuki H, Akakura K, Ueda T, Mikami K, Tobe T, Komiya A, Ichikawa T, Igarashi T, Ito H. Suzuki H, et al. Eur Urol. 2002 Feb;41(2):172-7. doi: 10.1016/s0302-2838(01)00036-7. Eur Urol. 2002. PMID: 12074405 Clinical Trial.

3

[Hormone dependency of prostate cancer].

Suzuki H, Ito H. Suzuki H, et al. Nihon Rinsho. 2002 Dec;60 Suppl 11:59-64. Nihon Rinsho. 2002. PMID: 12599546 Review. Japanese. No abstract available.

4

[Molecular analysis for prostate cancer].

Ueda T, Suzuki H, Ichikawa T. Ueda T, et al. Among authors: suzuki h. Nihon Rinsho. 2005 Feb;63(2):213-7. Nihon Rinsho. 2005. PMID: 15714968 Review. Japanese.

5

[New biomarkers for prostate cancer].

Suzuki H, Shimbo M, Ichikawa T. Suzuki H, et al. Nihon Rinsho. 2005 Feb;63(2):351-9. Nihon Rinsho. 2005. PMID: 15714991 Review. Japanese.

6

Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patients.

Sasaki T, Komiya A, Suzuki H, Shimbo M, Ueda T, Akakura K, Ichikawa T. Sasaki T, et al. Among authors: suzuki h. Eur Urol. 2005 Aug;48(2):224-9; discussion 229-30. doi: 10.1016/j.eururo.2005.03.017. Epub 2005 Apr 7. Eur Urol. 2005. PMID: 16005374

7

Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.

Tsuchiya N, Wang L, Suzuki H, Segawa T, Fukuda H, Narita S, Shimbo M, Kamoto T, Mitsumori K, Ichikawa T, Ogawa O, Nakamura A, Habuchi T. Tsuchiya N, et al. Among authors: suzuki h. J Clin Oncol. 2006 May 1;24(13):1982-9. doi: 10.1200/JCO.2005.02.9439. J Clin Oncol. 2006. PMID: 16648498

8

Monotherapy with carbon ion radiation for localized prostate cancer.

Shimazaki J, Akakura K, Suzuki H, Ichikawa T, Tsuji H, Ishikawa H, Harada M, Tsujii H. Shimazaki J, et al. Among authors: suzuki h. Jpn J Clin Oncol. 2006 May;36(5):290-4. doi: 10.1093/jjco/hyl030. Epub 2006 May 30. Jpn J Clin Oncol. 2006. PMID: 16735373

9

Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer.

Kato T, Suzuki H, Komiya A, Imamoto T, Naya Y, Tobe T, Ichikawa T. Kato T, et al. Among authors: suzuki h. Int J Urol. 2006 Jul;13(7):915-9. doi: 10.1111/j.1442-2042.2006.01440.x. Int J Urol. 2006. PMID: 16882055

10

Bisphosphonate and low-dose dexamethasone treatment for patients with hormone-refractory prostate cancer.

Ueda T, Suzuki H, Akakura K, Ishihara M, Kamiya N, Komiya A, Shimbo M, Suyama T, Sakamoto S, Ichikawa T. Ueda T, et al. Among authors: suzuki h. Hinyokika Kiyo. 2006 Jul;52(7):515-21. Hinyokika Kiyo. 2006. PMID: 16910582 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,941 results

Search Page